Article
Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
18 Jun 2020
Abstract excerpt
T cell receptor (TCR)-based adoptive T cell therapies (ACT) hold great promise for the treatment of cancer, as TCRs can cover a broad range of target antigens. Here we summarize basic, translational and clinical results that provide insight into the challenges and opportunities of TCR-based ACT. We review the characteristics of target antigens and conventional αβ-TCRs, and provide a summary of published clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
